Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/37203
Title: Hepatotoxicity after paracetamol overdose in a patient with cystic fibrosis despite early acetylcysteine and utility of microRNA to predict hepatotoxicity.
Authors: Graudins A. ;Wong A. ;Cheung B.;Nejad C.;Gantier M.
Institution: (Wong, Cheung, Graudins) Monash Toxicology Unit and Monash Emergency Medicine Service, Monash Health, Clayton, Australia (Wong, Graudins) Department of Medicine, Clinical Sciences at Monash Health, Monash University, Clayton, Australia (Nejad, Gantier) Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia (Nejad, Gantier) Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia
Issue Date: 24-Oct-2018
Copyright year: 2018
Publisher: Taylor and Francis Ltd (E-mail: healthcare.enquiries@informa.com)
Place of publication: United States
Publication information: Clinical Toxicology. 56 (10) (pp 904-906), 2018. Date of Publication: 03 Oct 2018.
Journal: Clinical Toxicology
Abstract: Case details: A 19-year-old girl presented to the emergency department following overdose of 10 g of paracetamol on a background history of cystic fibrosis. Paracetamol concentration was below the nomogram line, but was treated with acetylcysteine seven hours post-overdose given her symptomatology. Nineteen hours following her overdose she developed hepatotoxicity, despite early initiation of acetylcysteine. She was discharged well six days post-ingestion. On presentation, delta miRNA-122-miR483 was 20 times that of control patients, however, alanine aminotransferase was normal. Discussion(s): Patients with cystic fibrosis are more likely to have glutathione deficiency, and greater susceptibility to liver injury. Delta miRNA may be a better detector of early liver injury than hepatic aminotransferases. Empiric treatment with acetylcysteine and serial biochemical reassessment in this setting should be considered.Copyright © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1080/15563650.2018.1454596
ORCID: Wong, Anselm; ORCID: http://orcid.org/0000-0002-6817-7289 Gantier, Michael; ORCID: http://orcid.org/0000-0003-3740-698X
PubMed URL: 29564929 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29564929]
ISSN: 1556-3650
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/37203
Type: Article
Type of Clinical Study or Trial: Case series or case report
Appears in Collections:Articles

Show full item record

Page view(s)

18
checked on Feb 7, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.